Vaniqa
This article was originally published in The Tan Sheet
Executive Summary
Bristol-Myers Squibb's Rx facial hair remover can be pre-ordered on drugstore.com in advance of the product's mid-September launch, the online healthcare site announces Aug. 31. Patients pre-registering for Vaniqa "can expect their first prescription to be shipped by mid-September" and "will receive the drug prior to its availability at most other pharmacies," drugstore.com said. The drug, being co-promoted with Gillette, is a likely future switch candidate (1"The Tan Sheet" Aug. 7, p. 4)
You may also be interested in...
Vaniqa Rx Facial Hair Remover May Be Strong OTC Switch Candidate
Ongoing studies of Bristol-Myers Squibb's newly approved Vaniqa prescription hair removal drug could broaden the topical cream's target population to include men. FDA approved the product for removal of women's facial hair July 27.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands